Ranbaxy Laboratories has acquired 2 companies of its own. A total of 1 acquisition came from private equity firms.
Ranbaxy Laboratories’ largest acquisition to date was in 2006, when it acquired Terapia SA for $324M. Ranbaxy Laboratories has acquired in 2 countries. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to Ranbaxy Laboratories’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 1
- Total Countries Invested 2
- M&A Buy/Sell Connections 1